US Press Release
TPI Composites, Inc. Announces Third Quarter 2018 Earnings Results, 2019 Guidance and Preliminary Targets for 2020
Highlights
For the quarter ended
- Net sales of
$255.0 million - Total billings of
$240.7 million - Net income of
$9.5 million or$0.26 per diluted share - EBITDA of
$7.4 million , with an EBITDA margin of 2.9% - Adjusted EBITDA of
$17.6 million , with an Adjusted EBITDA margin of 6.9%
KPIs | Q3'18 | Q3'17 | |
Sets¹ | 589 | 739 | |
Estimated megawatts² | 1,625 | 1,796 | |
Dedicated manufacturing lines³ | 51 | 48 | |
Manufacturing lines installed⁴ | 39 | 38 | |
Manufacturing lines in startup⁵ | 5 | 10 | |
Manufacturing lines in transition⁶ | 6 | - |
- Number of wind blade sets (which consist of three wind blades) invoiced worldwide in the period.
- Estimated megawatts of energy capacity to be generated by wind blade sets invoiced in the period.
- Number of manufacturing lines that are dedicated to our customers under long-term supply agreements at the end of the period.
- Number of manufacturing lines installed and either in operation, startup or transition at the end of the period.
- Number of manufacturing lines in a startup phase during the pre-production and production ramp-up period.
- Number of manufacturing lines that were being transitioned to a new wind blade model during the period.
“We delivered solid operational and financial performance in the third quarter in which we exceeded our Adjusted EBITDA target,” said
“Our customers continue to invest with TPI through the addition of new outsourced blade capacity as well as increased transitions, both of which have impacted our near-term profitability but position us well for long-term growth. Our Adjusted EBITDA guidance for 2018 remains the same as we provided during our Q2 earnings call of
Third Quarter 2018 Financial Results
Net sales for the quarter increased by
Total cost of goods sold for the quarter was
General and administrative expenses for the three months ended
Net income for the quarter was
EBITDA for the quarter decreased to
Capital expenditures were
We ended the quarter with
2018 Outlook
For 2018, the Company is providing the following guidance:
- Net sales of between
$1.0 billion and$1.05 billion - Total billings of between
$1.0 billion and$1.05 billion - Adjusted EBITDA of between
$65 million and$70 million - Fully diluted earnings per share of between
$0.32 and$0.39 - Sets invoiced of between 2,420 and 2,440
- Average sales price per blade of between
$125,000 and$130,000 - Estimated megawatts of sets delivered of approximately 6,800
- Dedicated manufacturing lines at year end to be between 51 and 55
- Manufacturing lines installed at year end to be 43
- Manufacturing lines in startup during the year to be 17
- Manufacturing lines in transition during the year to be 15
- Startup and transition cost of between
$74 million and$75 million - Capital expenditures to be between
$85 million and$90 million (approx. 85% growth related) - Depreciation and amortization of between
$26.5 million and$27 million - Interest expense of between
$14 million and$14.5 million - Share-based compensation expense of between
$9 million and$9.25 million
2019 Guidance
For 2019, the Company is providing the following guidance:
- Net sales and total billings of between
$1.5 billion and$1.6 billion - Adjusted EBITDA of between
$120 million and$130 million - Fully diluted earnings per share of between
$1.24 and$1.35 - Sets invoiced of between 3,300 and 3,500
- Average sales price per blade of between
$135,000 and$140,000 - Estimated megawatts of sets delivered of approximately 9,800 to 10,400
- Dedicated manufacturing lines at year end to be between 62 and 65
- Manufacturing lines installed at year end to be 50 to 52
- Manufacturing lines in startup during the year to be 15
- Manufacturing lines in transition during the year to be 10
- Line utilization (based on lines under contract as of
December 31, 2018 ) of between 86% and 88% - Startup costs of between
$30 million and$33 million - Transition costs of between
$22 million and$25 million - Capital expenditures to be between
$95 million and$100 million (approx. 85% growth related) - Effective tax rate to be between 20% and 25%
- Depreciation and amortization of between
$40 million and$45 million - Interest expense of between
$12 million and$13 million - Share-based compensation expense of between
$9.5 million and$10 million
2020 Outlook
For 2020, the Company is providing the following targets:
- Net sales and total billings of between
$1.7 billion and$1.9 billion - Adjusted EBITDA of between
$170 million and$190 million
Conference Call and Webcast Information
About
Forward-Looking Statements
This release contains forward-looking statements which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements, among other things, concerning: effects on our financial statements and our financial outlook; our business strategy, including anticipated trends and developments in and management plans for our business and the wind industry and other markets in which we operate; our projected annual revenue growth; competition; future financial results, operating results, revenues, gross margin, operating expenses, profitability, products, projected costs, warranties, our ability to improve our operating margins, and capital expenditures. These forward-looking statements are often characterized by the use of words such as “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “seek,” “believe,” “forecast,” “foresee,” “likely,” “may,” “should,” “goal,” “target,” “might,” “will,” “could,” “predict,” “continue” and the negative or plural of these words and other comparable terminology. Forward-looking statements are only predictions based on our current expectations and our projections about future events. You should not place undue reliance on these forward-looking statements. We undertake no obligation to update any of these forward-looking statements for any reason. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include, but are not limited to, the matters discussed in “Risk Factors,” in our Annual Report on Form 10-K and other reports that we will file with the
Non-GAAP Definitions
This press release includes unaudited non-GAAP financial measures, including total billings, EBITDA, adjusted EBITDA, net cash/debt and free cash flow. We define total billings as total amounts billed from products and services that we are entitled to payment and have billed under the terms of our long-term supply agreements or other contractual arrangements. We define EBITDA as net income plus interest expense (including losses on extinguishment of debt and net of interest income), income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA plus share-based compensation expense plus or minus any gains or losses from foreign currency transactions. We define net cash/debt as the total principal amount of debt outstanding less unrestricted cash and cash equivalents. We define free cash flow as net cash flow generated from operating activities less capital expenditures. We present non-GAAP measures when we believe that the additional information is useful and meaningful to investors. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similar measures presented by other companies. The presentation of non-GAAP financial measures is not intended to be a substitute for, and should not be considered in isolation from, the financial measures reported in accordance with GAAP. See below for a reconciliation of certain non-GAAP financial measures to the comparable GAAP measures as well as our Investor Presentation which can be found in the Presentations section at www.tpicomposites.com.
Investor Relations
480-315-8742
investors@TPIComposites.com
| ||||||||||||||
TABLE ONE - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||
(UNAUDITED) | ||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||
(in thousands, except per share data) | 2018 | 2017 | 2018 | 2017 | ||||||||||
Net sales | $ | 254,976 | $ | 253,498 | $ | 739,567 | $ | 701,695 | ||||||
Cost of sales | 216,594 | 210,840 | 625,817 | 592,495 | ||||||||||
Startup and transition costs | 21,415 | 12,352 | 53,474 | 29,051 | ||||||||||
Total cost of goods sold | 238,009 | 223,192 | 679,291 | 621,546 | ||||||||||
Gross profit | 16,967 | 30,306 | 60,276 | 80,149 | ||||||||||
General and administrative expenses | 9,756 | 9,315 | 31,908 | 28,373 | ||||||||||
Income from operations | 7,211 | 20,991 | 28,368 | 51,776 | ||||||||||
Other income (expense): | ||||||||||||||
Interest income | 45 | 48 | 129 | 78 | ||||||||||
Interest expense | (2,323 | ) | (3,254 | ) | (8,376 | ) | (9,215 | ) | ||||||
Loss on extinguishment of debt | - | - | (3,397 | ) | - | |||||||||
Realized gain (loss) on foreign currency remeasurement | (8,181 | ) | 39 | (12,957 | ) | (2,575 | ) | |||||||
Miscellaneous income | 2,511 | 390 | 4,003 | 968 | ||||||||||
Total other expense | (7,948 | ) | (2,777 | ) | (20,598 | ) | (10,744 | ) | ||||||
Income (loss) before income taxes | (737 | ) | 18,214 | 7,770 | 41,032 | |||||||||
Income tax benefit (provision) | 10,269 | 3,523 | 6,357 | (4,505 | ) | |||||||||
Net income | $ | 9,532 | $ | 21,737 | $ | 14,127 | $ | 36,527 | ||||||
Weighted-average common shares outstanding: | ||||||||||||||
Basic | 34,419 | 33,891 | 34,212 | 33,789 | ||||||||||
Diluted | 36,282 | 35,015 | 35,946 | 34,748 | ||||||||||
Net income per common share: | ||||||||||||||
Basic | $ | 0.28 | $ | 0.64 | $ | 0.41 | $ | 1.08 | ||||||
Diluted | $ | 0.26 | $ | 0.62 | $ | 0.39 | $ | 1.05 | ||||||
Non-GAAP Measures (unaudited): | ||||||||||||||
Total billings | $ | 240,699 | $ | 256,404 | $ | 701,755 | $ | 698,833 | ||||||
EBITDA | $ | 7,419 | $ | 26,847 | $ | 38,494 | $ | 64,312 | ||||||
Adjusted EBITDA | $ | 17,572 | $ | 27,851 | $ | 58,422 | $ | 71,681 | ||||||
| ||||||
TABLE TWO - CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||
(UNAUDITED) | ||||||
(in thousands) | 2018 | 2017 | ||||
Current assets: | ||||||
Cash and cash equivalents | $ | 110,838 | $ | 148,113 | ||
Restricted cash | 2,845 | 3,849 | ||||
Accounts receivable | 117,066 | 121,576 | ||||
Contract assets | 122,265 | 105,619 | ||||
Prepaid expenses and other current assets | 25,036 | 27,507 | ||||
Inventories | 7,445 | 4,112 | ||||
Total current assets | 385,495 | 410,776 | ||||
Noncurrent assets: | ||||||
Property, plant, and equipment, net | 150,931 | 123,480 | ||||
Other noncurrent assets | 38,270 | 22,306 | ||||
Total assets | $ | 574,696 | $ | 556,562 | ||
Current liabilities: | ||||||
Accounts payable and accrued expenses | $ | 168,039 | $ | 167,175 | ||
Accrued warranty | 32,704 | 30,419 | ||||
Current maturities of long-term debt | 39,201 | 35,506 | ||||
Contract liabilities | 8,335 | 2,763 | ||||
Total current liabilities | 248,279 | 235,863 | ||||
Noncurrent liabilities: | ||||||
Long-term debt, net of debt issuance costs and | ||||||
current maturities | 93,583 | 85,879 | ||||
Other noncurrent liabilities | 4,284 | 4,938 | ||||
Total liabilities | 346,146 | 326,680 | ||||
Total stockholders' equity | 228,550 | 229,882 | ||||
Total liabilities and stockholders' equity | $ | 574,696 | $ | 556,562 | ||
Non-GAAP Measure (unaudited): | ||||||
Net cash (debt) | $ | (22,876 | ) | $ | 24,557 | |
| ||||||||||||||
TABLE THREE - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||
(UNAUDITED) | ||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||
(in thousands) | 2018 | 2017 | 2018 | 2017 | ||||||||||
Net cash provided by operating activities | $ | 14,660 | $ | 17,590 | $ | 17,195 | $ | 43,460 | ||||||
Net cash used in investing activities | (8,326 | ) | (8,585 | ) | (50,636 | ) | (35,312 | ) | ||||||
Net cash provided by (used in) financing activities | (11,247 | ) | 104 | (4,555 | ) | 5,026 | ||||||||
Impact of foreign exchange rates on cash, cash equivalents and restricted cash | 170 | 141 | (283 | ) | 305 | |||||||||
Cash, cash equivalents and restricted cash, beginning of period | 118,901 | 134,092 | 152,437 | 129,863 | ||||||||||
Cash, cash equivalents and restricted cash, end of period | $ | 114,158 | $ | 143,342 | $ | 114,158 | $ | 143,342 | ||||||
Non-GAAP Measure (unaudited): | ||||||||||||||
Free cash flow | $ | 6,334 | $ | 9,005 | $ | (33,441 | ) | $ | 8,148 | |||||
| |||||||||||||
TABLE FOUR - RECONCILIATION OF NON-GAAP MEASURES | |||||||||||||
(UNAUDITED) | |||||||||||||
Total billings is reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
(in thousands) | 2018 | 2017 | 2018 | 2017 | |||||||||
Net sales | $ | 254,976 | $ | 253,498 | $ | 739,567 | $ | 701,695 | |||||
Change in contract assets | (1,434 | ) | 2,895 | (24,526 | ) | (827 | ) | ||||||
Foreign exchange impact | (12,843 | ) | 11 | (13,286 | ) | (2,035 | ) | ||||||
Total billings | $ | 240,699 | $ | 256,404 | $ | 701,755 | $ | 698,833 | |||||
EBITDA and adjusted EBITDA are reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
(in thousands) | 2018 | 2017 | 2018 | 2017 | |||||||||
Net income | $ | 9,532 | $ | 21,737 | $ | 14,127 | $ | 36,527 | |||||
Adjustments: | |||||||||||||
Depreciation and amortization | 5,878 | 5,427 | 19,080 | 14,143 | |||||||||
Interest expense (net of interest income) | 2,278 | 3,206 | 8,247 | 9,137 | |||||||||
Loss on extinguishment of debt | - | - | 3,397 | - | |||||||||
Income tax provision (benefit) | (10,269 | ) | (3,523 | ) | (6,357 | ) | 4,505 | ||||||
EBITDA | 7,419 | 26,847 | 38,494 | 64,312 | |||||||||
Share-based compensation expense | 1,972 | 1,043 | 6,971 | 4,794 | |||||||||
Realized loss (gain) on foreign currency remeasurement | 8,181 | (39 | ) | 12,957 | 2,575 | ||||||||
Adjusted EBITDA | $ | 17,572 | $ | 27,851 | $ | 58,422 | $ | 71,681 | |||||
Free cash flow is reconciled as follows: | Three Months Ended | Nine Months Ended | |||||||||||
(in thousands) | 2018 | 2017 | 2018 | 2017 | |||||||||
Net cash provided by operating activities | $ | 14,660 | $ | 17,590 | $ | 17,195 | $ | 43,460 | |||||
Capital expenditures | (8,326 | ) | (8,585 | ) | (50,636 | ) | (35,312 | ) | |||||
Free cash flow | $ | 6,334 | $ | 9,005 | $ | (33,441 | ) | $ | 8,148 | ||||
Net cash (debt) is reconciled as follows: | |||||||||||||
(in thousands) | 2018 | 2017 | |||||||||||
Cash and cash equivalents | $ | 110,838 | $ | 148,113 | |||||||||
Less total debt, net of debt issuance costs | (132,784 | ) | (121,385 | ) | |||||||||
Less debt issuance costs | (930 | ) | (2,171 | ) | |||||||||
Net cash (debt) | $ | (22,876 | ) | $ | 24,557 | ||||||||